Nervonik is a medical device company developing cutting-edge peripheral nerve stimulation (PNS) solutions to treat chronic pain. Leveraging advanced, proprietary, wireless power, and closed-loop sensing technologies, Nervonik is committed to providing minimally invasive, effective, and patient-centric treatment options. Nervonik is focused on advancing clinical research and achieving regulatory milestones to bring its innovative therapies to market.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/04/25 | $13,000,000 | Series A |
Correlation Ventures Foothill Ventures US Venture Partners  | undisclosed |
